查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
2023-2030 年失禁設備的全球市場
市場調查報告書
商品編碼
1176601

2023-2030 年失禁設備的全球市場

Global Incontinence Devices Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 200 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場概覽

在預測期內（2023 年至 2030 年），失禁設備的市場規模預計將以 6.4% 的複合年增長率增長。

尿失禁是指尿液不自覺地從膀胱排出（尿失禁）或排便（大便失禁）。 指的是 尿失禁是一種廣泛存在的疾病，影響著全世界 2 億人。 尿失禁在女性中的發生率是男性的兩倍。

市場動態

推動全球失禁設備市場的主要因素是全球慢性病（例如膀胱過度活動症和腎結石）的增加、研發支出的增加以及老年人口的快速增長。 新產品推出的增加促進了失禁治療市場的增長。

與慢性病相關的失禁增加以及技術先進產品的推出預計將推動市場增長。

對這些失禁設備產品的研究不斷增加，以及老年人膀胱過度活動症等膀胱疾病的患病率不斷增加，將推動市場增長。 世界上慢性病的增加也推動了市場的增長。 根據美國疾病控制和預防中心 (CDC) 的數據，慢性腎髒病 (CKD) 在 45-64 歲 (13%) 和 65 歲以上 (38%) 人群中比 18-44 歲人群 (7%) 更常見). 我來了。 許多醫療保健公司正在加緊研發工作，以開發新穎、創新和技術先進的產品。

推動市場增長的關鍵因素包括患有泌尿系統疾病的老年人口增加、與腎結石等慢性病相關的失禁增加，以及創新設備的可用性增加。 此外，主要製造商增加新產品的研發和技術先進的產品供應也有望在市場增長中發揮重要作用。

各種新產品的發布、監管批准和研究都為市場的增長做出了貢獻。 例如，2021 年 11 月 10 日，開發治療壓力性尿失禁和盆腔器官脫垂手術產品的醫療器械公司 Caldera Medical 宣布批准了一款用於治療壓力性尿失禁的新產品 Desara TVez。 此次發布增加了 Cladella 最廣泛的產品組合，這些產品組合適用於苦苦應對壓力性尿失禁治療方案的女性。

與失禁手術相關的風險預計會阻礙市場增長。

但是，與失禁手術相關的風險包括暫時性排尿困難、尿路感染、膀胱過度活動症、腹股溝疼痛以及手術材料伸入陰道。 這些因素可能會阻礙市場增長。

缺乏認可度也是製約市場成長的一大因素。 在低收入國家，人們不知道失禁設備的使用，而且缺乏報銷方案阻礙了市場增長。

COVID-19 影響分析

疫情對全球金融預期、運營和危機應對策略產生了積極影響。 COVID-19 的爆發嚴重影響了醫療保健行業。 由於 Covid，膀胱過度活動症治療市場取得了巨大收益。 在 Covid 患者中也觀察到與膀胱相關的問題，例如膀胱過度活動症。 Covid 影響了患者的膀胱。 主要製造商已經啟動了各種研究和臨床試驗。 世界各地正在開展各種舉措、產品發布、合作和合併，推動市場增長。 例如，2022 年 7 月，Urovant Science 宣布與 Pierre Fabre Medicament 達成許可協議，在歐洲地區將用於治療膀胱過度活動症的 Vibegron 商業化。

內容

第一章研究方法與範圍

  • 調查方法
  • 調查目的和範圍

第 2 章市場定義和概述

第 3 章執行摘要

第四章市場動態

  • 市場影響因素
    • 司機
      • 與慢性病相關的尿失禁增加
      • 更多地推出技術先進的產品
    • 約束因素
      • 與失禁手術相關的風險
    • 商機
    • 影響分析

第五章行業分析

  • 波特的五力分析
  • 供應鏈分析
  • 定價分析

第 6 章 COVID-19 分析

  • COVID-19 市場分析
    • COVID-19 之前的市場情景
    • COVID-19 的當前市場情景
    • COVID-19 後或未來情景
  • COVID-19 期間的價格動態
  • 供需範圍
  • 大流行期間與市場相關的政府舉措
  • 製造商的戰略舉措
  • 總結

第 7 章按產品類型

  • 導尿管
    • 導尿管
    • 其他導尿管
  • 電刺激器
  • 陰道吊帶
    • 常規陰道吊帶
    • 高級陰道吊帶
    • 生物素
    • 其他
  • 人工尿道括約肌

第 8 章按類別

  • 口腔失禁治療裝置
  • 內部尿失禁裝置

第 9 章失禁類型

  • 壓力性尿失禁
  • 急迫性尿失禁
  • 溢出性尿失禁
  • 功能性尿失禁

第 10 章最終用戶

  • 醫院
  • 診所
  • 家庭護理

第11章按地區

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 其他歐洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 其他亞太地區
  • 中東和非洲

第12章競爭格局

  • 主要發展和戰略
  • 公司股票分析
  • 產品基準
  • 值得關注的主要公司名單

第13章公司簡介

  • B.Braun Melsungen AG
    • 公司概況
    • 產品組合和說明
    • 主要亮點
    • 財務摘要
  • ConvaTec Inc.
  • Coloplast Corp
  • BD
  • Promedon GmbH
  • Medtronic Plc
  • Wellspect HealthCare（Dentsply Sirona）
  • Hollister Incorporated
  • A.M.I. GmbH
  • Caldera Medical

第14章 DataM

簡介目錄
Product Code: DMMD53

Market Overview

Incontinence Devices Market size was valued at US$ XX million in 2023 and is estimated to reach US$ XX million by 2030, growing at a CAGR of 6.4% during the forecast period (2023-2030).

Incontinence refers to involuntary loss of urine from the bladder (urinary incontinence) or bowel motion, feces, or wind from the bowel (fecal or bowel incontinence). Urinary incontinence is a widespread medical condition that affects 200 million people worldwide. Urinary Incontinence is twice as common in women as in men.

Market Dynamics

The major factors driving the global incontinence devices market are an increase in chronic diseases such as overactive bladder or kidney stones globally, rising research and development expenditure and a surge in the geriatric population. An increase in novel product launches contributed to the growth of the incontinence devices market.

Increased incontinence associated with chronic conditions and technologically advanced product launches is expected to drive the market's growth.

The rising research on these incontinence device products and the growth in the prevalence of bladder disorders such as overactive bladder in the geriatric population will drive the market growth. An increase in chronic diseases globally is also aiding market growth. Chronic kidney disease (CKD) is more common in people aged 65 years or older (38%) than in people aged 45-64 years (13%) or 18-44 years (7%), according to the Centers for Disease Control and Prevention (CDC). There has been an increase in R&D activities by many healthcare companies to develop novel, innovative and technologically advanced products.

The key factors boosting the market growth include the rise in the geriatric population that suffers from urological conditions, the increase in incontinence associated with chronic conditions such as kidney stones and the availability of innovative devices. Moreover, the increase in research and development of novel products and the availability of technologically advanced products by key players are also expected to play a vital role in the market's growth.

Various novel product launches, regulatory approvals and research studies contribute to the market's growth. For instance, in November 10, 2021, Caldera Medical, a medical device company developing surgical products for stress urinary incontinence treatment and Pelvic Organ Prolapse, announced its clearance for the novel Desara TVez for treating stress urinary incontinence. This launch further expands Cladera's broadest product portfolio for women suffering from stress urinary incontinence treatment options.

The risks associated with incontinence surgery are expected to hamper the market's growth.

However, the risks associated with incontinence surgery include temporary difficulty urinating, urinary tract infection, development of an overactive bladder, groin pain and surgical material sticking out into the vagina. These factors may hinder the growth of the market.

Lack of awareness is also a leading factor restraining the market's growth. In low-income countries, people are unaware of incontinence device usage, and the unavailability of reimbursement scenarios hinders the market's growth.

COVID-19 Impact Analysis

The pandemic has positively impacted global financial expectations, operations and crisis response strategy. The COVID-19 outbreak has severely impacted the healthcare industry. The overactive bladder treatment market has experienced huge profits due to COVID. In covid patients, bladder-related problems such as overactive bladder were also observed. COVID affected the bladders of patients. Key manufacturers have started various research and clinical trials. Various initiatives, product launches, collaborations and mergers are happening worldwide, boosting the market's growth. For instance, in July 2022, Urovant Sciences announced its license agreement with Pierre Fabre Medicament for Vibegron commercialization for overactive bladder treatment in European Areas.

Segment Analysis

The electrical stimulation devices segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)

The electrical stimulation devices segment is the highest market holder in the global incontinence devices market. The global incontinence devices market is segmented based on product type as urinary catheters, electrical stimulation devices, vaginal slings, and artificial urinary sphincters. The electrical stimulation device segment is the largest market shareholder due to its high demand, advantages and usage, rising adoption of these incontinence devices, better results in bladder disorder patients and increased research and development activities, which are expected to remain high during the forecast period.

The electrical stimulation device or neurostimulation device utilizes an electrode that is implanted under the skin to stimulate nerves with electricity around the bladder. The electric signals traveling from the bladder to the brain are blocked with electricity reducing the symptoms of an overactive bladder are blocked. These therapies are of two types: sacral neuromodulation and percutaneous tibial nerve stimulation.

The growing number of regulatory approvals, technological advancements, product launches, and research/clinical trial studies drive the market's growth. For instance, in April 2021, Medtronic, the medical technology company, announced receiving approval from the United States Food and Drug Administration to continue the investigational device exemption trial for evaluating its implantable tibial neuromodulation device, an internally developed therapy specially developed for bladder incontinence symptom's relief.

Geographical Analysis

North America holds the largest market share in the global incontinence devices market.

North America dominates the global incontinence devices market, primarily due to its large population, excellent medical infrastructure, and rising number of bladder-related disorders. The market is expected to grow at a relatively moderate pace during the forecast period due to healthcare expenditure in the US. The market's significant size is attributed to the high medical expenditure. As per the National Association for Incontinence (NAFC), in North America, nearly 200 million people were affected by urinary incontinence in 2021. According to WomensHealth.gov, urinary incontinence is twice as common in men, whereas stress urinary incontinence is most common in pregnant women, giving birth and going through menopause.

Increasing expenditure on healthcare and raising awareness among people are also contributing to the market's growth in this region. Advancement of products for different types of incontinence, including stress incontinence, urge incontinence, overflow incontinence, functional incontinence, increase in pharmaceutical establishment across the region, government approvals, and key players in the region are contributing to the growth of the incontinence devices market.

Moreover, the growing number of product launches is responsible for the market's growth. Many key developments, regulatory approvals, technological advancements, collaborations, and agreements are taking place in this region. In Oct 2020, Essity health and hygiene company launched TENA SmartCare. It is a novel, reusable digital sensor for better incontinence care. It will be available for working professionals and home caregivers.

Competitive Landscape

The incontinence devices market is moderately competitive with local and global companies' presence. B. Braun Melsungen AG, ConvaTec Inc., Coloplast Corp, BD, Promedon GmbH, Medtronic Plc, Wellspect HealthCare (Dentsply Sirona), Hollister Incorporated, A.M.I. GmbH, Caldera Medical and more. The key players are adopting various growth strategies such as product launches, mergers & acquisitions, partnerships, and collaborations, contributing to the market's growth. For instance, in August 11, 2022, A.M.I. GmbH announced its partnership with Medistim Norge AS, an established provider of medical devices for Norwegian health institutions. This collaboration will extend Norge's product portfolio in urogynecology, coloproctology, and urology and will provide products and solutions for incontinence, pelvic organ prolapses and hemorrhoid patients.

B. Braun Melsungen AG.

Overview: B. Braun is a company that manufactures medical and pharmaceuticals device. Headquartered in Melsungen, Germany and founded in 1839. They provide services in around 60 countries that employ around 63,000 people. They have around 5,000 varieties of healthcare products.

Product Portfolio:

Actreen Mini Cath: Actreen Mini Cath is a urinary catheter that is short and specially designed for the self-catheterization of females. It is a modern and feminine design and is ready to use as a catheter.

The global incontinence devices market report would provide access to approx.: 45+ market data tables, 40+ figures and 200 (approximate) pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increased incontinence associated with chronic conditions
      • 4.1.1.2. Rising technologically advanced product launches
    • 4.1.2. Restraints:
      • 4.1.2.1. Risks associated with incontinence surgery
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1 Porter's Five Forces Analysis
  • 5.2 Supply Chain Analysis
  • 5.3 Pricing Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type
  • 7.2. Urinary Catheters *
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
    • 7.2.3. Foley Catheters
    • 7.2.4. Other Urinary Catheters
  • 7.3. Electrical Stimulation Devices
  • 7.4. Vaginal Slings
    • 7.4.1. Conventional Vaginal Slings
    • 7.4.2. Advanced Vaginal Slings
    • 7.4.3. Biotin
    • 7.4.4. Others
  • 7.5. Artificial Urinary Sphincters

8. By Category

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Category
    • 8.1.2. Market Attractiveness Index, By Category
  • 8.2. External Urinary Incontinence Devices *
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Internal Urinary Incontinence Devices

9. By Incontinence Type

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Incontinence Type
    • 9.1.2. Market Attractiveness Index, By Incontinence Type
  • 9.2. Stress Incontinence *
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Urge Incontinence
  • 9.4. Overflow Incontinence
  • 9.5. Functional Incontinence

10. By End-User

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.1.2. Market Attractiveness Index, By End-User
  • 10.2. Hospitals *
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 10.3. Clinics
  • 10.4. Homecare

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Category
    • 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Incontinence Type
    • 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1. U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Category
    • 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Incontinence Type
    • 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. U.K.
      • 11.3.7.3. France
      • 11.3.7.4. Italy
      • 11.3.7.5. Spain
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Category
    • 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Incontinence Type
    • 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Category
    • 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Incontinence Type
    • 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan
      • 11.5.7.4. Australia
      • 11.5.7.5. Rest of Asia Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Category
    • 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Incontinence Type
    • 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

12. Competitive Landscape

  • 12.1. Key Developments and Strategies
  • 12.2. Company Share Analysis
  • 12.3. Products Benchmarking
  • 12.4. List of Key Companies to Watch

13. Company Profiles

  • 13.1. B. Braun Melsungen AG *
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Key Highlights
    • 13.1.4. Financial Overview
  • 13.2. ConvaTec Inc.
  • 13.3. Coloplast Corp
  • 13.4. BD
  • 13.5. Promedon GmbH
  • 13.6. Medtronic Plc
  • 13.7. Wellspect HealthCare (Dentsply Sirona)
  • 13.8. Hollister Incorporated
  • 13.9. A.M.I. GmbH
  • 13.10. Caldera Medical

LIST NOT EXHAUSTIVE

14. Global Incontinence Devices Market - DataM

  • 14.1. Appendix
  • 14.2. About Us and End-User
  • 14.3. Contact Us